Modular Medical, Inc.

NasdaqCM MODD

Modular Medical, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -2,094.35%

Modular Medical, Inc. EBIT Margin is -2,094.35% for the Trailing 12 Months (TTM) ending September 30, 2024. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

NasdaqCM: MODD

Modular Medical, Inc.

CEO	Mr. James E. Besser
IPO Date	Feb. 10, 2022
Location	United States
Headquarters	16772 W. Bernardo Drive
Employees	39
Sector	Healthcare
Industries Medical Instruments 3D Printing Automobiles & Vehicles Autonomous Driving Biotechnology Clinical Trials Electric Vehicles (EVs) Robotics Smartphones

Description

Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.

Key trends

Past 5 years